Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. MRVL
3. SPY
4. NVDA
5. GOOGL
6. CHRW
7. OPCH
8. BBIO
9. APLD
10. AMD

Go back to Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat

Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook

January 25, 2023 7:30 AM EST

Fourth-quarter sales of $10.1 billion; full-year 2022 sales of $43.7 billionFull-year 2022 sales growth of 1.3 percent; organic sales growth of 6.4 percentFull-year 2022 GAAP diluted EPS of $3.91; adjusted diluted EPS of $5.34Continues to strengthen portfolio with steady cadence of new product approvals

ABBOTT PARK, Ill., Jan. 25, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2022.

Fourth-quarter sales of $10.1 billion, which were negatively impacted by an expected year-over-year decline in COVID-19 testing-related sales, decreased 12.0 percent on a reported basis... More